References
- Vierling J M. Epidemiology and clinical course of liver disease: Identification of candidates for liver transplantation. Hepatology 1984; 4: 8494
- Biland L, Duckert F, Prisender S, Nyman D. Quantitative estimation of coagulation factors in liver disease. The diagnostic and prognostic value of factor XIII, factor V, and plasminogen. Thromb Haemost 1978; 39: 646–656
- Cordova C, Violi F, Alessandri C, et al. Pre-kallikrein and factor VII as prognostic indexes of liver failure. Am J Clin Pathol 1986; 85: 579–582
- Stormorken H, Baklund A, Gallimore M, Ritland S. Chrornogenic substrate assay of plasma pre-kallikrein. With a note on its site of biosynthesis. Haemostasis 1978; 7(2–3)69–75
- Cordova C, Musca A, Viola F, et al. Prekallikrein behaviour in chronic active hepatitis and in cirrhotic patients. Haemostasis 1984; 14: 218–222
- Cordova C, Violi C, Alessandri C, et al. Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease. J Clin Pathol 1986; 39: 1003–1005
- Franco D, Durandy Y, Deporte Y, Bismuth H. Upper gastrointestinal haemorrhage in hepatic cirrhosis: causes and relation to hepatic failure and stress. Lancet 1977; 1: 218–220
- Pinell A E, Northam B E. New automated dye-binding method for serum albumin determination with bromcresol purple. Clin Chem 1978; 24: 80–86
- Friberger P, Gallimore M J. Description and evaluation of a new chromogenic substrate assay kit for the determination of prekallikrein in human plasma, L M Greenbaum, H S Margolius, I V Kinins. Plenum Press, New York 1986; 543–548
- Owren P A, Aas K. The control of dicumarol therapy and the quantitative determination of pro-thrombin and proconvertin. Scand J Clin Lab Invest 1951; 3: 201–208
- Hartz A J. Overlap Index: An alternative to sensitivity and specificity in comparing the utility of a laboratory test. Arch Pathol Lab Med 1984; 108: 65–67
- Campbell M J, Gardner M J. Calculating confidence intervals for some non-parametric analyses. Br Med J 1988; 296: 1454–1456
- Diem K, Lcntner C. Scientific tables7th ed. Ciba-Geigy Ltd., Basel 1975
- Flute P T. Clotting abnormalities in liver diseases. Prog Liver Dis 1977; 16: 301–311
- Roberts H R, Cederbaurn A I. The liver and blood coagulation: Physiology and pathology. Gastro-enterology 1972; 63: 297
- Duckert F. Behaviour of antithrombin III in liver disease. Scand J Gastroenterol 1973; 8(suppl 19)109–112
- Ragni M V, Lewis J H, Hasiba U, Spero J A. Pre-kallikrein (Fletcher factor) deficiency in clinical disease states. Thromb Res 1980; 18: 45–54
- Saito H, Poon M-C., Vivic W, et al. Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease. J Lab Clin Med 1978; 92: 84–95